Efficacy of High-dose Palliative Radiotherapy for Localised, Castration-resistant Prostate Cancer

HDPRT was well tolerated and provided a high rate of local control in a clinically localised castration-resistant prostate cancer population. Although prostate cancer remained the most frequent cause of death, some patients had extended survival without evidence of disease progression.